Baird Downgrades Zimmer Biomet Holdings to Neutral, Lowers Price Target to $100

Benzinga · 1d ago
Baird analyst Jeff Johnson downgrades Zimmer Biomet Holdings (NYSE:ZBH) from Outperform to Neutral and lowers the price target from $117 to $100.